NFKB1 and breast carcinoma: For example, NF-κB, a redox-sensitive transcription factor central to the cellular oxidative stress response, demonstrates clinical relevance as the DNA-binding activity of its p65 subunit shows a significant correlation with systemic levels of antioxidants in breast carcinoma patients [30].